C V Starr & Co. Inc.

In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 11, 2026), C V Starr & Co. Inc. reported 5 stock positions worth $187.3 million. Its top holding was SPDR Gold Shares (GLD) at 49.4% of the portfolio, followed by iShares Core MSCI Dev MKTS (IDEV, 18.0%) and iShares Core S&P Small-Cap E (IJR, 15.9%). Its holdings were unchanged from Q1 2026.

Most Recent 13F
Q2 2026
Location
NEW YORK, NY
CIK
0001340459
Portfolio Value
$187.3M (Q2 2026)
SEC Filing
0001140361-26-032243 ↗ filed Aug 11, 2026

Holdings Value

0$50.0M$100.0M$150.0M$200.0M$250.0M Q4 2024: $128.1M Q4 2024 Q1 2025: $129.8M Q1 2025 Q2 2025: $192.4M Q2 2025 Q3 2025: $216.6M Q3 2025 Q4 2025: $182.0M Q4 2025 Q1 2026: $191.8M Q1 2026 Q2 2026: $187.3M $187.3M Q2 2026

Holdings 5 stocks · $187.3M

GLD SPDR Gold Shares 49.45% 251,400 $92.6M No change
IDEV iShares Core MSCI Dev MKTS 18.00% 378,787 $33.7M No change
IJR iShares Core S&P Small-Cap E 15.87% 200,458 $29.7M No change
IVOO Vanguard S&P Mid-Cap 400 ETF 15.83% 227,427 $29.7M No change
CELU Celularity Inc. Class A 0.84% 764,069 $1.6M No change

Portfolio Sells Q1 2026 → Q2 2026

None this quarter.

Portfolio Buys Q1 2026 → Q2 2026

None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 5$187.3MGLD, IDEV, IJR, IVOO, CELU
Q1 2026 5$191.8MGLD, IDEV, IVOO, IJR, CELU
Q4 2025 5$182.0MGLD, IDEV, IVOO, IJR, CELU
Q3 2025 5$216.6MGLD, IDEV, IVOO, IJR, CELU
Q2 2025 5$192.4MGLD, IDEV, IVOO, IJR, CELU
Q1 2025 5$129.8MGLD, IEFA, MDY, VB, CELU
Q4 2024 6$128.1MGLD, IEFA, VO, IJR, AMZN